Symbicort
AstraZeneca wins US court ruling on Symbicort patent claims
March 3, 2021Research and Development AstraZeneca, Symbicort, law
A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …
GSK and Theravance see FDA nod for asthma indication
March 20, 2015Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol
An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …
AstraZeneca secures respiratory drugs from Almirall
July 30, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs
AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
IT problems at Swedish plant affect AstraZeneca
July 27, 2012Manufacturing and Production AstraZeneca, Nexium, Symbicort, financials
Software problems at a manufacturing facility operated by AstraZeneca in Sweden are having a material impact on the business, pegging …
Symbicort gains COPD indication
March 4, 2009Research and Development Symbicort
AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …
Latest content
FibroFind appoints Lee Borthwick as CEO
